The prepared list will become the basis for further work on the reimbursement of drug technologies included in the list.
The creation of a list of highly innovative drug technologies (TLI) hereafter referred to as the "TLI list" is a systemic solution aimed at supporting efforts to improve health and quality of life.
Process of selecting drug technologies for evaluation
Drugs for which the decision on marketing authorization in the central procedure in the European Union (EU) was issued from January 1, 2024 to December 31, 2024, for which marketing authorization decision...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at english@medexpress.pl.